India orders top drugmaker to halt eye medicine production at plant over quality lapses
30 Oct 2026, 07:14 PM

India orders top drugmaker to halt eye medicine production at plant over quality lapses

A
Asia News Channel
@asianewschannel
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.
Source Credit: channelnewsasia.com
Read Full Story
1

Comments (0)

Login to join the conversation